Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene-induced experimental lung cancer
- PMID: 16827807
- PMCID: PMC11159414
- DOI: 10.1111/j.1349-7006.2006.00224.x
Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene-induced experimental lung cancer
Abstract
Lung cancer is one of the leading causes of cancer death in the world and is notoriously difficult to treat effectively. In the present study, male Swiss albino mice were divided into five groups of six animals each: group I animals received corn oil orally and served as a control; group II cancer-induced animals received benzo(a)pyrene (50 mg/kg bodyweight dissolved in corn oil, orally) twice weekly for four successive weeks; group III cancer-bearing animals (after 12 weeks of induction) were treated with paclitaxel (33 mg/kg bodyweight, i.p.) once weekly for 4 weeks; group IV cancer-bearing animals were treated with paclitaxel along with Withania somnifera (400 mg/kg bodyweight) orally once weekly for 4 weeks; and group V animals constituted the drug control treated with paclitaxel along with W. somnifera. The serum, lung and liver were investigated biochemically for aryl hydrocarbon hydroxylase, gamma-glutamyl transpeptidase, 5'-nucleotidase, lactate dehydrogenase and protein-bound carbohydrate components (hexose, hexosamine and sialic acid). These enzyme activities were increased significantly in cancer-bearing animals compared with control animals. The elevation of these in cancer-bearing animals was indicative of the persistent deteriorating effect of benzo(a)pyrene in cancer-bearing animals. Our data suggest that paclitaxel, administered with W. somnifera, may extend its chemotherapeutic effect through modulating protein-bound carbohydrate levels and marker enzymes, as they are indicators of cancer. The combination of paclitaxel with W. somnifera could effectively treat the benzo(a)pyrene-induced lung cancer in mice by offering protection from reactive oxygen species damage and also by suppressing cell proliferation.
Figures




Similar articles
-
Combination therapeutic effect of cisplatin along with Solanum trilobatum on benzo(a)pyrene induced experimental lung carcinogenesis.Nat Prod Res. 2008;22(12):1094-106. doi: 10.1080/14786410802267601. Nat Prod Res. 2008. PMID: 18780251
-
Stabilization of membrane bound enzyme profiles and lipid peroxidation by Withania somnifera along with paclitaxel on benzo(a)pyrene induced experimental lung cancer.Mol Cell Biochem. 2006 Nov;292(1-2):13-7. doi: 10.1007/s11010-006-9121-y. Epub 2006 Sep 27. Mol Cell Biochem. 2006. PMID: 17003952
-
Enhancement of antitumor effect of paclitaxel in combination with immunomodulatory Withania somnifera on benzo(a)pyrene induced experimental lung cancer.Chem Biol Interact. 2006 Feb 25;159(3):180-5. doi: 10.1016/j.cbi.2005.11.003. Epub 2005 Dec 22. Chem Biol Interact. 2006. PMID: 16375880
-
Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology.Altern Med Rev. 2006 Dec;11(4):269-77. Altern Med Rev. 2006. PMID: 17176166 Review.
-
Withania somnifera improves semen quality by combating oxidative stress and cell death and improving essential metal concentrations.Reprod Biomed Online. 2011 May;22(5):421-7. doi: 10.1016/j.rbmo.2011.01.010. Epub 2011 Mar 8. Reprod Biomed Online. 2011. PMID: 21388887 Review.
Cited by
-
Combination of Ashwagandha Water Extract and Intermittent Fasting as a Therapy to Overcome Cisplatin Resistance in Breast Cancer: An in vitro and in vivo Study.Front Nutr. 2022 Jul 4;9:863619. doi: 10.3389/fnut.2022.863619. eCollection 2022. Front Nutr. 2022. PMID: 35859750 Free PMC article.
-
Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.Cancer Immunol Immunother. 2013 Nov;62(11):1663-73. doi: 10.1007/s00262-013-1470-2. Epub 2013 Aug 27. Cancer Immunol Immunother. 2013. PMID: 23982485 Free PMC article.
-
The use of African medicinal plants in cancer management.Front Pharmacol. 2023 Feb 14;14:1122388. doi: 10.3389/fphar.2023.1122388. eCollection 2023. Front Pharmacol. 2023. PMID: 36865913 Free PMC article. Review.
-
Beneficial effect of additional treatment with widely available anticancer agents in advanced small lung cell carcinoma: A case report.Mol Clin Oncol. 2018 Dec;9(6):647-650. doi: 10.3892/mco.2018.1736. Epub 2018 Oct 5. Mol Clin Oncol. 2018. PMID: 30546895 Free PMC article.
-
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.Molecules. 2017 Jan 24;22(2):191. doi: 10.3390/molecules22020191. Molecules. 2017. PMID: 28125040 Free PMC article. Review.
References
-
- Haugan A. Women who smoke: are women more susceptible to tobacco induced lung cancer? Carcinogenesis 2002; 23: 227–9. - PubMed
-
- Hucks RM. Pathological and biochemical aspects of tumor promotion. Carcinogenesis 1983; 4: 1209–14. - PubMed
-
- Conklin KA. Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000; 37: 1–18. - PubMed
-
- Wani MC, Taylor HL, Wall ME, Coggon P, MacPhail AT. Plant antitumor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia . J Am Chem Soc 1971; 93: 2325–7. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials